|
1
|
Smith RK, Carroll PM, Allard JD and Simon
MA: MASK, a large ankyrin repeat and KH domain-containing protein
involved in Drosophila receptor tyrosine kinase signaling.
Development. 129:71–82. 2002.PubMed/NCBI
|
|
2
|
Poulin F, Brueschke A and Sonenberg N:
Gene fusion and overlapping reading frames in the mammalian genes
for 4E-BP3 and MASK. J Biol Chem. 278:52290–52297. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li J, Mahajan A and Tsai MD: Ankyrin
repeat: A unique motif mediating protein-protein interactions.
Biochemistry. 45:15168–15178. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sedgwick SG and Smerdon SJ: The ankyrin
repeat: A diversity of interactions on a common structural
framework. Trends Biochem Sci. 24:311–316. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Valverde R, Edwards L and Regan L:
Structure and function of KH domains. FEBS J. 275:2712–2726. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fragiadaki M and Zeidler MP: Ankyrin
repeat and single KH domain 1 (ANKHD1) drives renal cancer cell
proliferation via binding to and altering a subset of miRNAs. J
Biol Chem. 293:9570–9579. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Traina F, Favaro PM, Medina Sde S, Duarte
Ada S, Winnischofer SM, Costa FF and Saad ST: ANKHD1, ankyrin
repeat and KH domain containing 1, is overexpressed in acute
leukemias and is associated with SHP2 in K562 cells. Biochim
Biophys Acta. 1762:828–834. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sansores-Garcia L, Atkins M, Moya IM,
Shahmoradgoli M, Tao C, Mills GB and Halder G: Mask is required for
the activity of the Hippo pathway effector Yki/YAP. Curr Biol.
23:229–235. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Du Toit A: Cell signalling: A new Hippo
pathway component. Nat Rev Mol Cell Biol. 14:1962013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao B, Tumaneng K and Guan KL: The Hippo
pathway in organ size control, tissue regeneration and stem cell
self-renewal. Nat Cell Biol. 13:877–883. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bao Y, Hata Y, Ikeda M and Withanage K:
Mammalian Hippo pathway: From development to cancer and beyond. J
Biochem. 149:361–379. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chan SW, Lim CJ, Chen L, Chong YF, Huang
C, Song H and Hong W: The Hippo pathway in biological control and
cancer development. J Cell Physiol. 226:928–939. 2011. View Article : Google Scholar
|
|
13
|
Espanel X and Sudol M: Yes-associated
protein and p53-binding protein-2 interact through their WW and SH3
domains. J Biol Chem. 276:14514–14523. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Komuro A, Nagai M, Navin NE and Sudol M:
WW domain-containing protein YAP associates with ErbB-4 and acts as
a co-transcriptional activator for the carboxyl-terminal fragment
of ErbB-4 that translocates to the nucleus. J Biol Chem.
278:33334–33341. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lapi E, Di Agostino S, Donzelli S, Gal H,
Domany E, Rechavi G, Pandolfi PP, Givol D, Strano S, Lu X and
Blandino G: PML, YAP, and p73 are components of a proapoptotic
autoregulatory feedback loop. Mol Cell. 32:803–814. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zaidi SK, Sullivan AJ, Medina R, Ito Y,
van Wijnen AJ, Stein JL, Lian JB and Stein GS: Tyrosine
phosphorylation controls Runx2-mediated subnuclear targeting of YAP
to repress transcription. EMBO J. 23:790–799. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang L, Ren F, Zhang Q, Chen Y, Wang B
and Jiang J: The TEAD/TEF family of transcription factor Scalloped
mediates Hippo signaling in organ size control. Dev Cell.
14:377–387. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu FX, Zhao B, Panupinthu N, Jewell JL,
Lian I, Wang LH, Zhao J, Yuan H, Tumaneng K, Li H, et al:
Regulation of the Hippo-YAP pathway by G-protein-coupled receptor
signaling. Cell. 150:780–791. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Enderle L and McNeill H: Hippo gains
weight: Added insights and complexity to pathway control. Sci
Signal. 6:re72013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Machado-Neto JA, Lazarini M, Favaro P,
Franchi GC Jr, Nowill AE, Saad ST and Traina F: ANKHD1, a novel
component of the Hippo signaling pathway, promotes YAP1 activation
and cell cycle progression in prostate cancer cells. Exp Cell Res.
324:137–145. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Travis WD, Brambilla E, Nicholson AG,
Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E,
Flieder DB, et al: The 2015 World Health Organization
Classification of Lung Tumors: Impact of genetic, clinical and
radiologic advances since the 2004 classification. J Thorac Oncol.
10:1243–1260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Goldstraw P: Updated staging system for
lung cancer. Surg Oncol Clin N Am. 20:655–666. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nishioka N, Inoue K, Adachi K, Kiyonari H,
Ota M, Ralston A, Yabuta N, Hirahara S, Stephenson RO, Ogonuki N,
et al: The Hippo signaling pathway components Lats and Yap pattern
Tead4 activity to distinguish mouse trophectoderm from inner cell
mass. Dev Cell. 16:398–410. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xin M, Kim Y, Sutherland LB, Murakami M,
Qi X, McAnally J, Porrello ER, Mahmoud AI, Tan W, Shelton JM, et
al: Hippo pathway effector Yap promotes cardiac regeneration. Proc
Natl Acad Sci USA. 110:13839–13844. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chang Y, Fu XR, Cui M, Li WM, Zhang L, Li
X, Li L, Sun ZC, Zhang XD, Li ZM, et al: Activated hippo signal
pathway inhibits cell proliferation and promotes apoptosis in NK/T
cell lymphoma cells. Cancer Med. 8:3892–3904. 2019.PubMed/NCBI
|
|
26
|
Dhyani A, Duarte AS, Machado-Neto JA,
Favaro P, Ortega MM and Olalla Saad ST: ANKHD1 regulates cell cycle
progression and proliferation in multiple myeloma cells. FEBS Lett.
586:4311–4318. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dhyani A, Machado-Neto JA, Favaro P and
Saad ST: ANKHD1 represses p21 (WAF1/CIP1) promoter and promotes
multiple myeloma cell growth. Eur J Cancer. 51:252–259. 2015.
View Article : Google Scholar
|
|
28
|
Machado-Neto JA, Lazarini M, Favaro P, de
Melo Campos P, Scopim-Ribeiro R, Franchi Junior GC, Nowill AE, Lima
PR, Costa FF, Benichou S, et al: ANKHD1 silencing inhibits Stathmin
1 activity, cell proliferation and migration of leukemia cells.
Biochim Biophys Acta. 1853:583–593. 2015. View Article : Google Scholar
|
|
29
|
Mosavi LK, Cammett TJ, Desrosiers DC and
Peng ZY: The ankyrin repeat as molecular architecture for protein
recognition. Protein Sci. 13:1435–1448. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sidor CM, Brain R and Thompson BJ: Mask
proteins are cofactors of Yorkie/YAP in the Hippo pathway. Curr
Biol. 23:223–228. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu
J, Lin JD, Wang CY, Chinnaiyan AM, et al: TEAD mediates
YAP-dependent gene induction and growth control. Genes Dev.
22:1962–1971. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hao Y, Chun A, Cheung K, Rashidi B and
Yang X: Tumor suppressor LATS1 is a negative regulator of oncogene
YAP. J Biol Chem. 283:5496–5509. 2008. View Article : Google Scholar
|
|
33
|
Oka T, Mazack V and Sudol M: Mst2 and Lats
kinases regulate apoptotic function of Yes kinase-associated
protein (YAP). J Biol Chem. 283:27534–27546. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Remue E: TAZ interacts with zonula
occludens-1 and -2 proteins in a PDZ-1 dependent manner. FEBS Lett.
584:175–180. 2010. View Article : Google Scholar
|
|
35
|
Ren F, Zhang L and Jiang J: Hippo
signaling regulates Yorkie nuclear localization and activity
through 14-3-3 dependent and independent mechanisms. Dev Biol.
337:303–312. 2010. View Article : Google Scholar :
|
|
36
|
Wu S, Liu Y, Zheng Y, Dong J and Pan D:
The TEAD/TEF family protein Scalloped mediates transcriptional
output of the Hippo growth-regulatory pathway. Dev Cell.
14:388–398. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao B, Li L, Tumaneng K, Wang CY and Guan
KL: A coordinated phosphorylation by Lats and CK1 regulates YAP
stability through SCF(beta-TRCP). Genes Dev. 24:72–85. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cottini F, Hideshima T, Xu C, Sattler M,
Dori M, Agnelli L, ten Hacken E, Bertilaccio MT, Antonini E, Neri
A, et al: Rescue of Hippo coactivator YAP1 triggers DNA
damage-induced apop-tosis in hematological cancers. Nat Med.
20:599–606. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Machado-Neto JA, de Melo Campos P, Olalla
Saad ST and Traina F: YAP1 expression in myelodysplastic syndromes
and acute leukemias. Leuk Lymphoma. 55:2413–2415. 2014. View Article : Google Scholar : PubMed/NCBI
|
